• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

切除活检显示粉刺型原位导管癌后发生隐匿性浸润性乳腺癌的风险。

The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.

作者信息

Hardman P D, Worth A, Lee U, Baird R M

机构信息

Division of Radiation Oncology, Cancer Control Agency of British Columbia, Vancouver.

出版信息

Can J Surg. 1989 Jan;32(1):56-60.

PMID:2535949
Abstract

Between Jan. 1, 1985 and Aug. 31, 1987, 62 in-situ ductal carcinomas with a predominantly comedo pattern were identified in 61 patients in British Columbia from excisional biopsy of a palpable or mammographically demonstrable lesion of a breast. The biopsies were intended to remove the lesion completely. Fifty-seven (92%) of the 61 patients required wide re-excision or total mastectomy, usually within a month of the initial biopsy. Occult invasive disease was demonstrated in 14 of the re-excision specimens (24.5%) and residual in-situ carcinoma was present in a further 24 (42.1%), giving an overall rate of residual disease of 66.6%. Axillary lymph nodes were sampled in 54 cases. Metastases were found in two cases (3.7%) and each was associated with occult infiltrating ductal carcinoma in the breast. This suggests that in-situ ductal carcinoma having a predominant comedo pattern may be more widespread and associated with a higher incidence of invasive ductal carcinoma than is generally believed.

摘要

1985年1月1日至1987年8月31日期间,在不列颠哥伦比亚省,通过对乳房可触及或乳腺X线检查可显示的病变进行切除活检,在61名患者中发现了62例主要为粉刺型的原位导管癌。活检旨在完全切除病变。61名患者中有57名(92%)需要进行广泛再次切除或全乳切除术,通常在初次活检后的一个月内进行。在14例再次切除标本中发现隐匿性浸润性疾病(24.5%),另有24例(42.1%)存在残留原位癌,残留疾病的总体发生率为66.6%。对54例患者进行了腋窝淋巴结取样。发现2例转移(3.7%),且每例均与乳腺隐匿性浸润性导管癌相关。这表明,主要为粉刺型的原位导管癌可能比一般认为的更为广泛,且与浸润性导管癌的更高发生率相关。

相似文献

1
The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.切除活检显示粉刺型原位导管癌后发生隐匿性浸润性乳腺癌的风险。
Can J Surg. 1989 Jan;32(1):56-60.
2
Wide excision of primary breast cancer: the incidence of residual carcinoma at the site of excision.原发性乳腺癌的广泛切除:切除部位残留癌的发生率。
Ann R Coll Surg Engl. 1988 Jul;70(4):246-8.
3
Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.导管内乳腺癌是否呈节段性扩散?一项使用瘤床活检对节段性乳房切除术后残余肿瘤负荷的分析。
Eur J Surg Oncol. 2001 Feb;27(1):21-5. doi: 10.1053/ejso.2000.1051.
4
Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy.全乳切除术后手术引流皮肤端原位导管癌的晚期复发
Am Surg. 1993 Jul;59(7):410-4.
5
In situ ductal carcinoma of the breast: implications of disease pattern and treatment.乳腺原位导管癌:疾病模式与治疗的意义
Eur J Surg Oncol. 1986 Sep;12(3):261-6.
6
Ductal carcinoma in situ: value of sentinel lymph node biopsy.导管原位癌:前哨淋巴结活检的价值
J Surg Oncol. 2006 Oct 1;94(5):426-30. doi: 10.1002/jso.20578.
7
Significance of incisional biopsy in breast carcinoma: results from a clinical trial with intended excisional biopsy.乳腺浸润性癌切取活检的意义:一项旨在进行切除活检的临床试验结果
Eur J Surg Oncol. 1989 Feb;15(1):33-7.
8
Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.经粗针活检诊断的导管原位癌的浸润及腋窝淋巴结转移风险
Br J Surg. 2007 Aug;94(8):952-6. doi: 10.1002/bjs.5735.
9
[The role of sentinel lymph node biopsy in breast cancer non-invading-duct].前哨淋巴结活检在乳腺非浸润性导管癌中的作用
Magy Seb. 2006 Jun;59(3):173-8.
10
Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.双侧及多灶性乳腺癌。一项特别关注原位癌的临床与尸检研究。
Eur J Surg Oncol. 1991 Feb;17(1):20-9.

引用本文的文献

1
Sentinel Lymph Node Biopsy Should Be Included with the Initial Surgery for High-Risk Ductal Carcinoma-In-Situ.前哨淋巴结活检应包含在高危导管原位癌的初次手术中。
Int Sch Res Notices. 2014 Oct 29;2014:624185. doi: 10.1155/2014/624185. eCollection 2014.
2
Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.导管原位癌的前哨淋巴结活检及腋窝处理
J Natl Cancer Inst Monogr. 2010;2010(41):145-9. doi: 10.1093/jncimonographs/lgq026.
3
Management of in situ and minimally invasive breast carcinoma.原位及微创性乳腺癌的管理
World J Surg. 1994 Jan-Feb;18(1):45-57. doi: 10.1007/BF00348191.
4
Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.浸润性乳腺癌的预后变量:粉刺型与非粉刺型原位成分的作用。
Ann Surg Oncol. 1995 Sep;2(5):440-4. doi: 10.1007/BF02306378.